Self-adjuvanting multicomponent cancer vaccine candidates combining per-glycosylated MUC1 glycopeptides and the Toll-like receptor 2 agonist Pam3CysSer. (Q39594793)

From Wikidata

Jump to navigation Jump to search

scientific article published on 7 January 2011

Language	Label	Description	Also known as
English	Self-adjuvanting multicomponent cancer vaccine candidates combining per-glycosylated MUC1 glycopeptides and the Toll-like receptor 2 agonist Pam3CysSer.	scientific article published on 7 January 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21308921%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Self-adjuvanting multicomponent cancer vaccine candidates combining per-glycosylated MUC1 glycopeptides and the Toll-like receptor 2 agonist Pam3CysSer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21308921%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

toll-like receptor

0 references

1 reference

based on heuristic

inferred from title

Brendan L. Wilkinson

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21308921%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21308921%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Vasso Apostolopoulos

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21308921%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Stephanie Day

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21308921%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Richard J Payne

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21308921%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

language of work or name

0 references

publication date

7 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21308921%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Angewandte Chemie International Edition

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21308921%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

50

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21308921%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21308921%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1635-1639

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21308921%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Lewis blood group and CEA related antigens; coexpressed cell-cell adhesion molecules with roles in the biological progression and dissemination of tumours

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201006115

21 January 2018

MUC1 and cancer

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201006115

21 January 2018

Immunotherapy for cancer: synthetic carbohydrate-based vaccines

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201006115

21 January 2018

Carbohydrate vaccines: developing sweet solutions to sticky situations?

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201006115

21 January 2018

From the Laboratory to the Clinic: A Retrospective on Fully Synthetic Carbohydrate-Based Anticancer Vaccines Frequently used abbreviations are listed in the appendix

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201006115

21 January 2018

Synthesis of glycoproteins

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201006115

21 January 2018

Synthetic vaccines consisting of tumor-associated MUC1 glycopeptide antigens and a T-cell epitope for the induction of a highly specific humoral immune response

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201006115

21 January 2018

Synthetic Antitumor Vaccines from Tetanus Toxoid Conjugates of MUC1 Glycopeptides with the Thomsen–Friedenreich Antigen and a Fluorine‐Substituted Analogue

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201006115

21 January 2018

The immunogenicity of the tumor-associated antigen Lewis(y) may be suppressed by a bifunctional cross-linker required for coupling to a carrier protein

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201006115

21 January 2018

Toward a carbohydrate-based HIV-1 vaccine: synthesis and immunological studies of oligomannose-containing glycoconjugates

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201006115

21 January 2018

Novel low-molecular-weight synthetic vaccine against foot-and-mouth disease containing a potent B-cell and macrophage activator

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201006115

21 January 2018

Bacterial cell wall components as immunomodulators--I. Lipopeptides as adjuvants for parenteral and oral immunization

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201006115

21 January 2018

Protection of mice against SV40 tumours by Pam3Cys, MTP-PE and Pam3Cys conjugated with the SV40 T antigen-derived peptide, K(698)-T(708).

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201006115

21 January 2018

Increasing the antigenicity of synthetic tumor-associated carbohydrate antigens by targeting Toll-like receptors

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201006115

21 January 2018

Robust immune responses elicited by a fully synthetic three-component vaccine

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201006115

21 January 2018

A peptide carrier with a built-in vaccine adjuvant: construction of immunogenic conjugates

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201006115

21 January 2018

Towards a self-adjuvanting multivalent B and T cell epitope containing synthetic glycolipopeptide cancer vaccine.

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201006115

21 January 2018

Synthetic lipopeptide adjuvants and Toll-like receptor 2--structure-activity relationships

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201006115

21 January 2018

Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance.

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201006115

21 January 2018

Synthesis and biological evaluation of a multiantigenic Tn/TF-containing glycopeptide mimic of the tumor-related MUC1 glycoprotein

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201006115

21 January 2018

Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn.

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201006115

21 January 2018

Designer glycopeptides for cytotoxic T cell-based elimination of carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201006115

21 January 2018

Definition of MHC-restricted CTL epitopes from non-variable number of tandem repeat sequence of MUC1.

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201006115

21 January 2018

Towards a Fully Synthetic Carbohydrate-Based Anticancer Vaccine: Synthesis and Immunological Evaluation of a Lipidated Glycopeptide Containing the Tumor-Associated Tn Antigen

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201006115

21 January 2018

Identifiers

10.1002/ANIE.201006115

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21308921%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21308921%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39594793&oldid=1473729647"